[Drug treatment of alopecia].
Study Design
- Tipo de Estudo
- Other
- População
- alopecia areata patients
- Intervenção
- [Drug treatment of alopecia]. 1 mg
- Comparador
- None
- Desfecho Primário
- None
- Direção do Efeito
- Mixed
- Risco de Viés
- Unclear
Abstract
BACKGROUND: Alopecia is the term used to describe hairless areas of the scalp. They can follow a specific pattern, be diffuse or circumscript. Androgenetic alopecia (AGA) follows a pattern: in men thinning of temples and vertex up to total baldness; in women thinning of the midline or parietal area. CAUSES: Lack of iron or cytostatic drugs cause diffuse alopecia, while in autoimmune diseases such as alopecia areata or lichen planus bizarre shapes of hairless areas are observed. TREATMENT: For therapy, the following medications are used: topical minoxidil solution for AGA of men and women; systemic finasteride 1 mg for men with AGA; topical diphencyprone immunotherapy for alopecia areata; systemic antimycotic agents for tinea capitis; antibiotics such as clindamycin and rifampicin for folliculitis decalvans; systemic corticosteroids and isotretinoin for folliculitis et perifolliculitis capitis abscedens et suffodiens; topical corticosteroids for lichen planus and Kossard's frontal fibrosing alopecia.
Resumo Rápido
Androgenetic alopecia (AGA) follows a pattern: in menthinning of temples and vertex up to total baldness; in women thinning of the midline or parietal area.
Used In Evidence Reviews
Similar Papers
The British journal of nutrition · 2002
The immune system: a target for functional foods?
Clinical reviews in allergy & immunology · 2021
Alopecia Areata: an Update on Etiopathogenesis, Diagnosis, and Management.
World journal of gastroenterology · 2016
Diet and nutritional factors in inflammatory bowel diseases.
Glia · 1997
Glucocorticoid- and mineralocorticoid receptors in microglial cells: the two receptors mediate differential effects of corticosteroids.
American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists · 1999
Unsafe and potentially safe herbal therapies.
European journal of obstetrics, gynecology, and reproductive biology · 2012